The clinical effects of insulin glargine combined with novonorm in treatment of patients with newly diagnosed type 2 diabetes
10.3760/cma.j.issn.1008-6706.2011.02.016
- VernacularTitle:甘精胰岛素联合瑞格列奈治疗初诊2型糖尿病的临床分析
- Author:
Haiyang LIN
;
Cheng XUE
;
Xiaojie MAO
;
Enfu CHEN
;
Gaofeng RAO
;
Jinyou WU
- Publication Type:Journal Article
- Keywords:
Diabetes,type 2;
Insulin glargine;
Novonorm
- From:
Chinese Journal of Primary Medicine and Pharmacy
2011;18(2):177-179
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the clinical effects of insulin glargine combined with novonorm in treatment of patients with newly diagnosed type 2 diabetes. Methods 112 cases of newly diagnosed type 2 diabetes patients were randomly separated into observation group(56 cases)and control group(56 cases). Observation group was treated with insulin glargine combined with novonorm. Control group was treated with novolin30R. The levels of FPG,2hPG and HbA1c before and after treatment,the control time of blood sugar,amounts of insulin and incidence of low blood sugar were observed in both groups. Results Compared with pre-treatment, FPG,2hPG and HbA1 c were significantly decreased (all P ＜0.05) after treatment, but there were no significant differences in both two groups (P ＞0. 05). The control time of blood sugar, amounts of insulin and incidence of low blood sugar in observation group were significantly lower than those in control group (all P ＜ 0.05). Conclusion Insulin glargine combined with novonorm in treatment of patients with newly diagnosed type 2 diabetes could effectively control blood sugar,shorten the control time of blood sugar,decrease amounts of insulin,and low incidence of low blood sugar.
